Cryotherapy is the application of extremely cold, used in minimally invasive procedure to reduce pain and destroy tumor. It is useful in treating conditions and problems such as skin problems, heart diseases, injuries, improving immunity, and increasing blood pressure. The global cryotherapy market is growing at significant rate, due to escalating occurrence of cardiovascular diseases and cancer and mounting acceptance of minimally invasive procedure. Different products contributed to the cryotherapy market size. The market has witnessed high demand for devices over the last few years due to mounting acceptance of minimally invasive procedure and technological improvement of devices.
Globally, the manufacturing companies trying to enter the cryotherapy market are required to maintain stringent regulatory standards. This offers an edge to the established players in the industry competition. Moreover, companies are promptly collaborating with athletics organizations, sports clubs, and other corresponding business suppliers to continue their business growth.
Geographically, North America is the largest cryotherapy market as in the region the prevalence of cardiovascular diseases and cancer are mounting. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Moreover, according to CDC, approximately 370,000 people die annually due to coronary heart disease in the U.S. It is the most common type of heart disease in the U.S. In addition, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.
Moreover, boosting acceptance of cryosaunas, escalating number of product launches, existence of well-developed healthcare organization, and escalating number of cardiac arrest cases in Canada are also up surging growth of the North American cryotherapy market.
Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base and mounting acceptance of minimally invasive procedure. In addition, escalating occurrence of cardiovascular diseases and cancer, speedy growth in geriatric population, boosting medical tourism, mounting healthcare expenditure and refining healthcare infrastructure are also creating a positive impact on the cryotherapy industry growth in the region.
Key players in the cryotherapy market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In October 2015, Galil Medical, launched IcePearl 2.1 CX Cryoablation Needle and IceFORCE 2.1 CX Cryoablation Needle into its cryoablation family. Medtronic PLC, ERBE Elektromedizin GmbH, Impact Cryotherapy, Cryoconcepts LP, Zimmer Medizinsysteme GmbH, Kriosystem Life, Metrum Cryoflex, Brymill Cryogenic Systems, US Cryotherapy, Galil Medical, and Coopersurgical, are the key players offering cryo products.
Contact
VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook
No comments:
Post a Comment